isoleucine and kw 2449

isoleucine has been researched along with kw 2449 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, A; Akinaga, S; Akiyama, T; Ishii, K; Ishikawa, Y; Kanda, Y; Kiyoi, H; Maeda, H; Minami, Y; Mori, Y; Naoe, T; Ozeki, K; Sato, Y; Shimizu, M; Shiotsu, Y; Tanizaki, R; Umehara, H1

Other Studies

1 other study(ies) available for isoleucine and kw 2449

ArticleYear
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.
    Blood, 2009, Aug-20, Volume: 114, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Indazoles; Isoleucine; K562 Cells; Leukemia; Male; Mice; Mice, Inbred C3H; Mice, SCID; Mutation, Missense; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Threonine; Translocation, Genetic

2009